It begins with your cells
268 AXL activation mediates both intrinsic and acquired resistance to targeted therapies (e.g., EGFR-TKIs in NSCLC, HER2 inhibitors in breast cancer), chemotherapy (e.g., cisplatin, gemcitabine), and antiangiogenic agents (e.g., bevacizumab)
Unlike oral L-carnitine supplements that get partially lost through digestion, l-carnitine iv infusion delivers levocarnitine directly into your bloodstream, ensuring near-complete bioavailability
28 The objective of the trial was to compare the addition of oral semaglutide (14 mg once daily) or the sodium-glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin (25 mg once daily) to metformin monotherapy in patients with uncontrolled T2DM
N Engl J Med 390(15):13941407
SUD, Substance Use Disorder